Journey Medical (DERM)
(Delayed Data from NSDQ)
$4.83 USD
+0.32 (7.10%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.87 +0.04 (0.83%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.17 | -23.53% |
Earnings Summary
For their last quarter, Journey Medical (DERM) reported earnings of -$0.17 per share, missing the Zacks Consensus Estimate of -$0.15 per share. This reflects a negative earnings surprise of 13.33%. Look out for DERM's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year decrease of 121.25%.
Earnings History
Price & Consensus
Zacks News for DERM
Oncternal Therapeutics (ONCT) Reports Q2 Loss, Tops Revenue Estimates
DERM: What are Zacks experts saying now?
Zacks Private Portfolio Services